Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Themis

National Institute for Health and Care Excellence NICE logo

NICE backs biosimilars in rheumatoid arthritis guidance

Seven biologic drugs (DMARDs) and two biosimilars recommended

Cubist’s Dr Lorianne Masuoka jumps ship to InVivo

Comes amidst MSD’s recent takeover of the antibiotic specialist

- PMLiVE

Global pledge to immunise 300 million children

Commitment made at GAVI Pledging Conference follows criticism of high vaccine prices

- PMLiVE

Call for GSK and Pfizer to reduce vaccine price

MSF campaigns to lower cost of pneumococcal shot to $5 per child in developing countries

China flag thumb

China approves home-grown polio vaccine

Country clamps down on recent outbreaks of disease

- PMLiVE

Gates Foundation sponsors arts campaign to promote vaccination

Social media will play a role in raising awareness for the project

- PMLiVE

NICE backs three ulcerative colitis treatments

Remicade, Simponi and Humira recommended for NHS reimbursement

- PMLiVE

Pfizer teams up with snowboarder in meningitis campaign

Amy Purdy won bronze medal at 2014 Paralympic games

- PMLiVE

Italy investigates Novartis vaccine after death toll reaches 13

Firms insist on the Fluad's safety, with 65 million doses given in the last 17 years

- PMLiVE

First trial results positive for GSK Ebola vaccine

ChAd3-EBO is safe and able to stimulate response

- PMLiVE

Merck buys rights to NewLink’s Ebola vaccine

Drug is set to enter large phase III study in early 2015

EU flag

Orphan drugs in latest CHMP recommendations

EMA advisers back new products from Genzyme, Boehringer and others

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links